Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.606060606061 | 1.65 | 1.9 | 1.6001 | 90236 | 1.73257314 | CS |
4 | -0.18 | -9.89010989011 | 1.82 | 1.9 | 1.43 | 67307 | 1.64010807 | CS |
12 | -0.54 | -24.7706422018 | 2.18 | 7.2 | 1.35 | 2632669 | 2.7416295 | CS |
26 | -4.344 | -72.5935828877 | 5.984 | 7.2 | 1.35 | 1277315 | 2.78937865 | CS |
52 | -4.1192 | -71.5238227532 | 5.7592 | 7.6 | 1.35 | 664693 | 2.88682006 | CS |
156 | -222.36 | -99.2678571429 | 224 | 240 | 1.35 | 476832 | 36.96777062 | CS |
260 | -1260.36 | -99.8700475436 | 1262 | 1350 | 1.35 | 667457 | 183.68189417 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.